发明名称 Modulating disease through genetic engineering of plants
摘要 In certain embodiments transgenic plants (e.g., transgenic tomatoes) are provided that comprise cells that express a peptide one or more domains of which comprise the amino acid sequence of an apolipoprotein or apolipoprotein mimetic peptide where the peptide has biological activity (e.g., lowers SAA, and/or increases paroxonase activity, and/or improves HDL inflammatory index, etc.) when the plant and/or the peptide is fed to a mammal.
申请公布号 US9539300(B2) 申请公布日期 2017.01.10
申请号 US201313789513 申请日期 2013.03.07
申请人 The Regents of the University of California 发明人 Fogelman Alan M.;Reddy Srinivasa T.;Navab Mohamad
分类号 A61K38/10;C12N15/63;C07K14/775;A61K36/81;C12N15/82 主分类号 A61K38/10
代理机构 Weaver Austin Villeneuve & Sampson LLP 代理人 Hunter Tom;Weaver Austin Villeneuve & Sampson LLP
主权项 1. A transgenic tomato plant comprising cells that express a peptide one or more domains of which comprise the amino acid sequence DWLKAFYDKFFEKFKEFF (SEQ ID NO: 17) wherein said peptide in a fruit of said plant is effective to decrease plasma levels of lysophosphatidic acid (LPA) in a mammal, and/or to decrease serum amyloid A (SAA) levels in said mammal, and/or to increase plasma paraoxonase activity in said mammal when said fruit is fed to said mammal as a lyophilized powder.
地址 Oakland CA US